NovaQuest Pharma Opportunities Fund V, L.P. — Form D/A
NovaQuest Pharma Opportunities Fund V, L.P. of RALEIGH, NC, a pooled investment fund, filed a Form D amendment with the SEC on 2019-06-21. The offering totals $1.5B, of which $892.8M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2019-06-21
- Form: D/A
- Accession: 0001707710-19-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Total offering: $1.5B
- Amount sold: $892.8M
- Remaining: $607.3M
- Investors: 13
- Date of first sale: 2017-06-28
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-289380
Issuer
- Name: NovaQuest Pharma Opportunities Fund V, L.P.
- CIK: 0001707710
- Entity type: Limited Partnership
- Jurisdiction: CAYMAN ISLANDS
- Incorporated: 2016
- Address: 4208 SIX FORKS ROAD, RALEIGH, NC, 27609
- Phone: 919-459-8620
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| John L Bradley, Jr. | Director | Raleigh, NC |
| Ernest Gerald Brown | Director | Raleigh, NC |
| Manabu Gerald Ikegami | Director | Raleigh, NC |
| Ronald Gerald Wooten | Director | Raleigh, NC |
| N/A NQ POF V GP, L.P. | Executive Officer | Raleigh, NC |
| N/A NQ POF V GP, Ltd. | Executive Officer | Raleigh, NC |
| Ikegami Gerald Manabu | Director | Raleigh, NC |
Other filings by this issuer (2)
More